[1]薛 昭,张卓红.肺癌新辅助化疗患者血清C-反应蛋白、降钙素原和细胞角蛋白19片段抗原表达与肺部感染严重程度评分关系[J].陕西医学杂志,2022,51(10):1227-1231.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.012]
　XUE Zhao,ZHANG Zhuohong.Correlation between expression levels of serum CRP,PCT,CYFRA21-1 and severity score of pulmonary infection in patients with lung cancer undergoing neoadjuvant chemotherapy[J].,2022,51(10):1227-1231.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.012]
点击复制

肺癌新辅助化疗患者血清C-反应蛋白、降钙素原和细胞角蛋白19片段抗原表达与肺部感染严重程度评分关系
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年10期
页码:
1227-1231
栏目:
临床研究
出版日期:
2022-10-05

文章信息/Info

Title:
Correlation between expression levels of serum CRP,PCT,CYFRA21-1 and severity score of pulmonary infection in patients with lung cancer undergoing neoadjuvant chemotherapy
作者:
薛 昭1; 张卓红2
(1.咸阳市第一人民医院肿瘤科,陕西 咸阳 712000; 2.西电集团医院呼吸与危重症医学科,陕西 西安 710077)
Author(s):
XUE Zhao; ZHANG Zhuohong
(Department of Oncology,the First People's Hospital of Xianyang,Xianyang 712000,China)
关键词:
肺癌;  新辅助化疗;  肺部感染;  C-反应蛋白;  降钙素原;  细胞角蛋白19片段抗原;  相关性
Keywords:
Lung cancer;  Neoadjuvant chemotherapy;  Pulmonary infection;  C-reactive protein;  Procalcitonin;  Cytokeratin 19 fragment antigen 21-1;  Correlation
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7377.2022.10.012
文献标志码:
A
摘要:
目的:研究肺癌新辅助化疗(NACT)患者血清C-反应蛋白(CRP)、降钙素原(PCT)和细胞角蛋白19片段抗原(CYFRA21-1)表达水平与肺部感染严重程度评分(PSI)的关系。方法:回顾性收集76例行NACT治疗的肺癌患者作为研究对象,收集所有患者的临床资料,应用PSI评分评价并发肺部感染患者的严重程度,检测各患者血清CRP、PCT和CYFRA21-1的表达水平。结果:76例患者行NACT后,共30例(39.47%)发生肺部感染,46例未发生肺部感染(60.53%); 30例肺部感染患者中,依据PSI评分,可分为轻度7例(23.33%)、中度14例(46.67%)、重度9例(30.00%)。感染组和非感染组患者在性别、体重指数(BMI)、病程和病理分型方面相比无统计学差异(均P>0.05); 而在年龄、是否有吸烟史、是否合并高血压和糖尿病以及TNM分期方面比较有统计学差异(均P<0.05)。感染组患者血清CRP、PCT和CYFRA21-1的表达水平均显著高于非感染组患者(均P<0.05)。轻度、中度和重度感染患者之间血清CRP、PCT和CYFRA21-1的表达水平相比有统计学差异(均P<0.05)。Pearson相关性分析显示,患者血清CRP、PCT和CYFRA21-1的表达水平与PSI得分呈正相关(均P<0.05)。多元线性回归分析显示,血清CRP(OR=1.852,95%CI:1.669～2.054)、PCT(OR=1.255,95%CI:1.118～1.409)和CYFRA21-1(OR=2.421,95%CI:1.311～4.470)的表达水平均为肺癌患者行NACT后发生肺部感染的独立危险因素。结论:肺癌NACT患者血清CRP、PCT和CYFRA21-1表达与术后并发肺部感染的严重程度密切相关,可作为早期诊断和评估感染严重程度的重要生物学指标。
Abstract:
Objective:To investigate the correlation between expression levels of serum C-reactive protein(CRP),procalcitonin(PCT),cytokeratin 19 fragment antigen 21-1(CYFRA21-1)and severity score of pulmonary infection in patients with lung cancer undergoing neoadjuvant chemotherapy(NACT).Methods:A total of 76 patients with lung cancer underwent NACT were accepted as research subjects.The clinical data of all patients were collected.The severity of pulmonary infection was evaluated by PSI score,and the expression levels of CRP,PCT and CYFRA21-1 in serum were detected.Results:After 76 patients underwent NACT,30 patients(39.47%)had pulmonary infection,and 46 patients had no pulmonary infection(60.53%).Among the 30 patients with pulmonary infection,according to PSI score,they were divided into mild(7 cases,23.33%),moderate(14 cases,46.67%)and severe(9 cases,30.00%).The sexuality,BMI,course of disease and pathological type of infected group and non-infected group had no significant difference(all P>0.05),while age,whether coexist smoking history,hypertension,diabetes and TNM stage were significantly different(all P<0.05).The expression levels of serum CRP,PCT and CYFRA21-1 of infected group were higher than those of non-infected group(all P<0.05).The expression levels of serum CRP,PCT and CYFRA21-1 between mild,moderate and severe group had significant difference(all P<0.05).Pearson correlation analysis showed that the expression levels of serum CRP,PCT and CYFRA21-1 were positively correlated with PSI score(P<0.05).Multiple linear regression analysis showed that the expression levels of serum CRP(OR=1.852,95%CI:1.669 to 2.054),PCT(OR=1.255,95%CI:1.118 to 1.409)and CYFRA21-1(OR=2.421,95%CI:1.311 to 4.470)were independently associated with pulmonary infection in patients with lung cancer undergoing NACT.Conclusion:The expression levels of serum CRP,PCT and CYFRA21-1 were closely related with severity of pulmonary infection in patients with lung cancer undergoing NACT,which can be important biological indicators for early diagnosis and evaluation of severity of pulmonary infection.

参考文献/References:

[1] Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics,2021[J].CA:A Cancer Journal for Clinicians,2021,71(1):7-33.
[2] Heynemann S,Mitchell P.Developments in systemic therapies for the management of lung cancer[J].Internal Medicine Journal,2021,51(12):2012-2020.
[3] Kraus KM,Oechsner M,Wilkens JJ,et al.Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer(NSCLC)[J].Scientific Reports,2021,11(1):5870.
[4] Cascone T,William WN,Weissferdt A.et al.Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer:The phase 2 randomized NEOSTAR trial[J].Nat Med,2021,27(3):504-514.
[5] Provencio M,Nadal E,Insa A,et al.Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer(NADIM):An open-label,multicentre,single-arm,phase 2 trial[J].The Lancet Oncology,2020,21(11):1413-1422.
[6] 乔树林,胡宏凯,荣守华,等.高迁移率族蛋白B1多态性与肺癌化疗患者肺部感染严重程度的相关性[J].中华医院感染学杂志,2021,31(2):198-202.
[7] 支修益,杨 跃,王长利,等.原发性肺癌诊疗规范(2015年版):外科部分[J].中国医学前沿杂志:电子版,2015,7(2):28-31.
[8] 中华医学会呼吸病学分会.肺部感染性疾病支气管肺泡灌洗病原体检测中国专家共识(2017年版)[J].中华结核和呼吸杂志,2017,40(8):578-583.
[9] Mizgerd JP.Pathogenesis of severe pneumonia:Advances and knowledge gaps[J].Cur Opin Pulm Med,2017,23(3):193-197.
[10] Bade BC,Cruz CSD.Lung cancer 2020:Epidemiology,etiology,and prevention[J].Clinics in Chest Medicine,2020,41(1):1-24.
[11] 中国抗癌协会肺癌专业委员会,中华医学会肿瘤学分会肺癌学组.Ⅲ期非小细胞肺癌多学科诊疗专家共识(2019版)[S].中华肿瘤杂志,2019,41(12):881-890.
[12] 魏玉磊,崔玉环,董跃华,等.新辅助化疗对ⅢA-N2期肺癌淋巴结转移率的影响及预后生存分析[J].中华医学杂志,2021,101(4):259-264.
[13] Schreiner W,Dudek W,Rieker RJ,et al.Major pathologic response after induction therapy has a long-term impact on survival and tumor recurrence in stage Ⅲa/blocally advanced NSCLC[J].Thorac Cardio Vasc Surg,2020,68(7):639-645.
[14] 邹灵俊,陈洪波,郭晓康,等.非小细胞肺癌新辅助化疗联合手术预后影响因素分析[J].中华肿瘤防治杂志,2022,29(3):179-185.
[15] 刘 洁,王 斐,杨 侠,等.黄连解毒汤对重度颅脑损伤合并肺部感染患者血气指标和炎症因子影响分析[J].陕西中医,2020,41(3):318-320,349.
[16] 王 婷,韦小碗,杨 亮,等.脓毒症患者血清PCT、CRP、IL-6和IL-10水平检测及临床意义[J].陕西医学杂志,2020,49(11):1510-1514.
[17] 薛 刚,郭 华,白 洁.肺癌化疗并发肺部感染患者血清炎性因子水平检测的意义[J].中国肿瘤临床与康复,2022,29(2):167-170.
[18] 刘 军,张 雷,李洪林,等.血清降钙素原与前白蛋白对肺癌患者术后肺部感染的诊断效果研究[J].中华医院感染学杂志,2019,29(20):3096-3100.
[19] 黄一灵,丁 宁,林 蔚.miR-21联合Cyfra21-1、CEA检测在良恶性胸腔积液鉴别诊断中的价值[J].肿瘤学杂志,2020,26(3):262-264.
[20] 刘 鹭,程建平,金 跃.血清ProGRP、HE4、CA153、CEA和CYFRA21-1联合检测在肺部良恶性疾病中的临床价值[J].标记免疫分析与临床,2018,25(1):99-101,112.

相似文献/References:

[1]贾丽娟,杜苏丰.重组新城疫病毒疫苗rlRVG对A549荷瘤小鼠瘤体生长的抑制作用[J].陕西医学杂志,2019,(1):6.
　JIA Lijuan,DU Sufeng..The tumor growth influence of recombinant NDV (rlRVG) on lung adenocarcinoma A549transfected in vivo[J].,2019,(10):6.
[2]江茂琼,贾钰铭△,叶文静,等.MDSCs对肺癌小鼠CD8+T细胞及生存期的影响研究[J].陕西医学杂志,2019,(3):293.
　JIANG Maoqiong,JIA Yuming,LI Ting,et al.Effect of MDSCs on CD8 T cells and survival time of lung cancer mice[J].,2019,(10):293.
[3]李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系*[J].陕西医学杂志,2019,(6):718.
　LI Junyan,CHEN Guorong..The relationships between coagulation indicators and clinic characterisitics of patients with lung cancer[J].,2019,(10):718.
[4]王 玲,申 鸿.癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究*[J].陕西医学杂志,2019,(8):1080.
　WANG Ling,SHEN Hong..The value of tumor markers CEA，CA199，CA125，Ang-2，CYFRA211 and AFP in the diagnosis of lung cancer[J].,2019,(10):1080.
[5]韩 乐,陈文娟△,雷光焰,等.microRNA21、microRNA25在肺癌组织中的表达及意义*[J].陕西医学杂志,2019,(12):1596.
　HAN Le,CHEN Wenjuan,LEI Guangyan,et al.Expression and significance of microRNA21 and microRNA25 in lung cancer tissues[J].,2019,(10):1596.
[6]王 勇,张 勇,白正忠△.单操作孔完全胸腔镜与传统三孔胸腔镜治疗老年肺癌疗效对比研究*[J].陕西医学杂志,2019,(12):1670.
[7]韩丕华,袁 权△.乳腺癌患者白细胞介素-22表达水平对新辅助化疗后病理学完全缓解的预测价值*[J].陕西医学杂志,2020,49(7):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
　HAN Pihua,YUAN Quan..Predictive value of IL-22 expression level in breast cancer patients for pathological complete remission after neoadjuvant chemotherapy[J].,2020,49(10):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
[8]钟 亮,廖荣伟,刘清壮,等.调强适形放疗联合新辅助化疗治疗上下行型鼻咽癌疗效研究*[J].陕西医学杂志,2020,49(8):964.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.013]
　ZHONG Liang,LIAO Rongwei,LIU Qingzhuang,et al.Effect of intensity-modulated radiotherapy combined with neoadjuvant chemotherapy in treatment of ascending and descending types of nasopharyngeal carcinoma[J].,2020,49(10):964.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.013]
[9]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
　CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(10):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[10]米卫国.负压引流管在单操作孔胸腔镜下肺癌根治术中的临床应用研究[J].陕西医学杂志,2021,50(7):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
　MI Weiguo.Application effect of negative pressure drainage tube in patients undergoing radical surgery for lung cancer under single-port thoracoscopy[J].,2021,50(10):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划一般项目-社会发展领域(2017SF-068)
更新日期/Last Update: 2022-10-07